185 related articles for article (PubMed ID: 17537052)
21. [Conclude that clinical trials on the overall effectiveness of interferon? Contribution of recent data].
Boulinguez S; Grange F
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H21-4. PubMed ID: 21703461
[No Abstract] [Full Text] [Related]
22. Adjuvant interferon therapy and rheumatoid arthritis--a contraindication?
Tsianakas A; Schiller M; Luger TA; Sunderkoetter C
Acta Oncol; 2009; 48(3):468-9. PubMed ID: 18759142
[No Abstract] [Full Text] [Related]
23. Adjuvant high-dose interferon therapy for high-risk melanoma.
Ready N; Weinstock MA
Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
[No Abstract] [Full Text] [Related]
24. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
25. Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
Radny P; Bauer J; Caroli UM; Eigentler TK; Kamin A; Metzler G; Garbe C
Dermatology; 2004; 209(3):249-50. PubMed ID: 15459547
[No Abstract] [Full Text] [Related]
26. Interferon adjuvant therapy of melanoma.
Nathanson L
Cancer; 1996 Sep; 78(5):944-7. PubMed ID: 8780530
[No Abstract] [Full Text] [Related]
27. [Current chemo- and hormone therapy in disseminated malignant melanoma of the skin].
Akimov MA; Gershanovich ML
Vopr Onkol; 1999; 45(4):341-9. PubMed ID: 10532089
[No Abstract] [Full Text] [Related]
28. Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitis.
Lebiedz P; August C; Domschke W; Schmidt HH
Eur J Intern Med; 2009 Jan; 20(1):e3-4. PubMed ID: 19237078
[No Abstract] [Full Text] [Related]
29. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous head and neck melanoma: the old and the new.
Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
[TBL] [Abstract][Full Text] [Related]
31. Towards a rational perfusion strategy for malignant melanoma.
Rampen FH
Eur J Surg Oncol; 1985 Jun; 11(2):117-8. PubMed ID: 4007168
[No Abstract] [Full Text] [Related]
32. [Underutilization of anticancer agents--an example].
Strannegård O; Thorén FB
Lakartidningen; 2010 Dec 8-14; 107(49):3150; discussion 3150-1. PubMed ID: 21280349
[No Abstract] [Full Text] [Related]
33. Adjuvant therapy of cutaneous melanoma -- current status.
Hansson J
Acta Oncol; 2006; 45(4):369-72. PubMed ID: 16760171
[No Abstract] [Full Text] [Related]
34. Care of the patient undergoing interferon therapy.
Garvey EC; Matutat RJ; Bolten D
Cancer Nurs; 1983 Aug; 6(4):303-6. PubMed ID: 6192903
[No Abstract] [Full Text] [Related]
35. Randomized adjuvant therapy trials in melanoma: surgical and systemic.
Eggermont AM; Gore M
Semin Oncol; 2007 Dec; 34(6):509-15. PubMed ID: 18083374
[TBL] [Abstract][Full Text] [Related]
36. A potential predictive marker for response to interferon in malignant melanoma.
Wild PJ; Meyer S; Landthaler M; Hofstaedter F; Bosserhoff AK
J Dtsch Dermatol Ges; 2007 Jun; 5(6):456-9. PubMed ID: 17537037
[TBL] [Abstract][Full Text] [Related]
37. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
[TBL] [Abstract][Full Text] [Related]
38. [Perspectives opened by intra-arterial chemotherapy in treatment of malignant cutaneous melanoma].
Dargent M; Colon J; Mayer M; Moyne C; Estigarribia A
Mem Acad Chir (Paris); 1967 Oct; 93(22):678-90. PubMed ID: 5623685
[No Abstract] [Full Text] [Related]
39. [Chemotherapy of melanoma].
Bernheim JL; Kenis Y
Acta Chir Belg; 1974 Mar; 73(2):249-63. PubMed ID: 4450922
[No Abstract] [Full Text] [Related]
40. Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results.
Egberts F; Kahler KC; Livingstone E; Hauschild A
Onkologie; 2008 Jul; 31(7):398-403. PubMed ID: 18596389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
